Ubs Global Asset Management Americas »

Rhythm Pharmaceuticals shares owned by Ubs Global Asset Management Americas

Quarter-by-quarter ownership of Rhythm Pharmaceuticals (RYTM) shares owned by Ubs Global Asset Management Americas from 13F filings

Historical chart of Ubs Global Asset Management Americas investment in Rhythm Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rhythm Pharmaceuticals held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rhythm Pharmaceuticals by Ubs Global Asset Management Americas

Quarter filed Position value Share count Share price at filing
2024-03-31 $9.0M 207k 43.33
2023-12-31 $9.7M 210k 45.97
2023-09-30 $7.7M 337k 22.93
2023-06-30 $3.7M 206k 17.84
2023-03-31 $3.7M 206k 17.84
2022-12-31 $1.2M 42k 29.12
2022-09-30 $734k 30k 24.50
2022-06-30 $228k 55k 4.15
2022-03-31 $339k 29k 11.52
2021-12-31 $294k 29k 9.98
2021-09-30 $329k 25k 13.06
2021-06-30 $494k 25k 19.58
2021-03-31 $223k 11k 21.27
2020-12-31 $693k 32k 21.67
2020-09-30 $693k 32k 21.67
2020-06-30 $425k 19k 22.30